{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:30:19Z","timestamp":1759336219896},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.3500","type":"journal-article","created":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T18:17:55Z","timestamp":1438366675000},"page":"1833-1840","source":"Crossref","is-referenced-by-count":13,"title":["Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis"],"prefix":"10.2169","volume":"54","author":[{"given":"Satoshi","family":"Yuda","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Japan"},{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yasui","sequence":"additional","affiliation":[{"name":"Division of Laboratory Diagnosis, Sapporo Medical University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Muranaka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Japan"},{"name":"Department of Public Health, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazufumi","family":"Tsuchihashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Shinomura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mohty D, Damy T, Cosnay P, et al. Cardiac amyloidosis: updates in diagnosis and management. Arch Cardiovasc Dis 106: 528-540, 2013.","DOI":"10.1016\/j.acvd.2013.06.051"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kapoor P, Thenappan T, Singh E, Kumar S, Greipp PR. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med 124: 1006-1015, 2011.","DOI":"10.1016\/j.amjmed.2011.04.013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bellavia D, Pellikka PA, Al-Zahrani GB, et al. Independent predictors of survival in primary systemic (AL) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 23: 643-652, 2010.","DOI":"10.1016\/j.echo.2010.03.027"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Koyama J, Falk RH. Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3: 333-342, 2010.","DOI":"10.1016\/j.jcmg.2009.11.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Palladini G, Barassi A, Klersy C, et al. The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis. Blood 116: 3426-3430, 2010.","DOI":"10.1182\/blood-2010-05-286567"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kristen AV, Giannitsis E, Lehrke S, et al. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood 116: 2455-2461, 2010.","DOI":"10.1182\/blood-2010-02-267708"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mohty D, Pibarot P, Dumesnil JG, et al. Left atrial size is an independent predictor of overall survival in patients with primary systemic amyloidosis. Arch Cardiovasc Dis 104: 611-618, 2011.","DOI":"10.1016\/j.acvd.2011.10.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Buss SJ, Emami M, Mereles D, et al. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol 60: 1067-1076, 2012.","DOI":"10.1016\/j.jacc.2012.04.043"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Cappelli F, Porciani MC, Bergesio F, et al. Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 13: 416-422, 2012.","DOI":"10.1093\/ejechocard\/jer289"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Bellavia D, Pellikka PA, Dispenzieri A, et al. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study. Eur Heart J Cardiovasc Imaging 13: 680-689, 2012.","DOI":"10.1093\/ehjci\/jes009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Liu D, Hu K, Niemann M, et al. Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS ONE 8: e56923, 2013.","DOI":"10.1371\/journal.pone.0056923"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Osawa Y, Kawamura K, Kondo D, et al. Renal function at the time of renal biopsy as a predictor of prognosis in patients with primary AL-type amyloidosis. Clin Exp Nephrol 8: 127-133, 2004.","DOI":"10.1007\/s10157-004-0286-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matsuda M, Yamada T, Gono T, et al. Serum levels of free light chain before and after chemotherapy in primary systemic AL amyloidosis. Intern Med 44: 428-433, 2005.","DOI":"10.2169\/internalmedicine.44.428"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jun HJ, Kim K, Kim SJ, et al. Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: results of multicenter analysis. Am J Hematol 88: 52-55, 2013.","DOI":"10.1002\/ajh.23333"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lee MH, Lee SP, Kim YJ, Sohn DW. Incidence, diagnosis and prognosis of cardiac amyloidosis. Korean Circ J 43: 752-760, 2013.","DOI":"10.4070\/kcj.2013.43.11.752"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Carson P, Ziesche S, Johnson G, Cohn JN. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials: Vasodilator-Heart Failure Trial Study Group. J Card Fail 5: 178-187, 1999.","DOI":"10.1016\/S1071-9164(99)90001-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. East MA, Peterson ED, Shaw LK, Gattis WA, O'Connor CM. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J 148: 151-156, 2004.","DOI":"10.1016\/j.ahj.2004.01.017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus option from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 79: 319-328, 2005.","DOI":"10.1002\/ajh.20381"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography, endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 23: 685-713, 2010.","DOI":"10.1016\/j.echo.2010.05.010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 26: 965-1012, 2013.","DOI":"10.1016\/j.echo.2013.06.023"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102: 1788-1794, 2000.","DOI":"10.1161\/01.CIR.102.15.1788"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Yamada H, Goh PP, Sun JP, et al. Prevalence of left ventricular diastolic dysfunction by Doppler echocardiography: clinical application of the Canadian consensus guidelines. J Am Soc Echocardiogr 15: 1238-1244, 2002.","DOI":"10.1067\/mje.2002.124877"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289: 194-202, 2003.","DOI":"10.1001\/jama.289.2.194"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Marenzi G, Moltrasio M, Assanelli E, et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angiplasty. Am Heart J 153: 755-762, 2007.","DOI":"10.1016\/j.ahj.2007.02.018"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mollee PN, Wechalekar AD, Pereira DL, et al. Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplant 33: 271-277, 2004.","DOI":"10.1038\/sj.bmt.1704344"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood 99: 4276-4282, 2002.","DOI":"10.1182\/blood.V99.12.4276"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Navarro JF, Rivera M, Ortuño J. Cardiac tamponade as presentation of systemic amyloidosis. Int J Cardiol 36: 107-108, 1992.","DOI":"10.1016\/0167-5273(92)90115-J"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Toyama K, Oka H, Obata K, Ogawa H. Primary systemic amyloidosis with bloody pericardial effusion. Intern Med 48: 821-826, 2009.","DOI":"10.2169\/internalmedicine.48.1846"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Piper C, Butz T, Farr M, Faber L, Oldenburg O, Horstkotte D. How to diagnose cardiac amyloidosis early: impact of ECG, tissue Doppler echocardiography, and myocardial biopsy. Amyloid 17: 1-9, 2010.","DOI":"10.3109\/13506121003619310"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ahmad S, Ellis J, Nesbitt A, Molyneux E. Pericardial effusions in children with severe protein energy malnutrition resolve with therapeutic feeding: a prospective cohort study. Arch Dis Child 93: 1033-1036, 2008.","DOI":"10.1136\/adc.2007.136747"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Caccialanza R, Palladini G, Klersy C, et al. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1. Am J Clin Nutr 83: 350-354, 2006.","DOI":"10.1093\/ajcn\/83.2.350"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Fenstad ER, Le RJ, Sinak LJ, et al. Pericardial effusions in pulmonary arterial hypertension: characteristics, prognosis, and role of drainage. Chest 144: 1530-1538, 2013.","DOI":"10.1378\/chest.12-3033"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Russo C, Green P, Maurer M. The prognostic significance of central hemodynamics in patients with cardiac amyloidosis. Amyloid 20: 199-203, 2013.","DOI":"10.3109\/13506129.2013.821406"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systemic review of 118 studies. J Hepatol 44: 217-231, 2006.","DOI":"10.1016\/j.jhep.2005.10.013"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. De Sutter J, De Backer J, Van de Veire N, Velghe A, De Buyzere M, Gillebert TC. Effects of age, gender, and left ventricular mass on septal mitral annulus velocity (E') and the ratio of trasmitral early peak velocity to E' (E\/E'). Am J Cardiol 95: 1020-1023, 2005.","DOI":"10.1016\/j.amjcard.2005.01.021"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mekinian A, Lions C, Leleu X, et al. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging. Am J Med 123: 864-868, 2010.","DOI":"10.1016\/j.amjmed.2010.03.022"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Appleton CP, Hatle LK, Popp RL. Cardiac tamponade and pericardial effusion: respiratory variation in transvalvular flow velocities studied by Doppler echocardiography. J Am Coll Cardiol 11: 1020-1030, 1988.","DOI":"10.1016\/S0735-1097(98)90060-2"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Burstow DJ, Oh JK, Bailey KR, Seward JB, Tajik AJ. Cardiac tamponade: characteristic Doppler observations. Mayo Clin Proc 64: 312-324, 1989.","DOI":"10.1016\/S0025-6196(12)65251-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/15\/54_54.3500\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T19:51:32Z","timestamp":1567021892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/15\/54_54.3500\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":39,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.3500","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}